Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of small molecule compound in preparation of anti-depression drug

A small molecule compound, antidepressant technology, applied in the field of medicine, can solve the problems of large side effects, unsatisfactory drug requirements, poor specificity of MIF inhibitor NAPQI, etc., and achieves the effect of low cytotoxicity and good development prospects.

Active Publication Date: 2021-08-06
SUZHOU UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The first discovered MIF inhibitor NAPQI has poor specificity and side effects
The pharmacokinetic properties of 4-IPP inhibitors are poor and do not meet the conditions for drug preparation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of small molecule compound in preparation of anti-depression drug
  • Application of small molecule compound in preparation of anti-depression drug
  • Application of small molecule compound in preparation of anti-depression drug

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0017] In order to make the above objects, features and advantages of the present invention more obvious and comprehensible, the technical solution of the present invention will be further described below in conjunction with the examples. But the present invention is not limited to the listed embodiments, but also includes any other known changes within the claimed scope of the present invention.

[0018] Reference herein to "one embodiment" or "an embodiment" refers to a particular feature, structure or characteristic that can be included in at least one implementation of the present invention. "In one embodiment" appearing in different places in this specification does not all refer to the same embodiment, nor is it a separate or selective embodiment that is mutually exclusive with other embodiments.

[0019] The present invention discovers the small molecule compound N-(2-(1-(4-chlorophenyl)-5-hydroxyl-3-phenyl-1hydrogen-pyrazol-4-yl) through virtual screening software base...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of a small molecule compound, the small molecule compound is N-(2-(1-(4-chlorphenyl)-5-hydroxy-3-phenyl-1-hydro-pyrazole-4-yl)-2-acetyl)-4-methyl-N-propyl benzamide, the chemical structural formula of the small molecule compound is shown in the specification, and the small molecule compound has a relatively strong inhibition effect on MIF. The small molecule compound has obvious inhibition effect on microglial cell activation and inflammatory factor release, has low cytotoxicity, has good development prospect, is expected to be developed into a novel MIF inhibitor, is expected to be developed into a novel medicine for resisting central system inflammation, and especially is expected to be developed into a novel medicine for treating depression.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to the application of a small molecular compound in the preparation of MIF inhibitors and antidepressant drugs. Background technique [0002] Depression is the most prevalent mental illness in today's society. According to statistics from the World Health Organization (WHO) in 2019, there are more than 350 million depressed patients worldwide, and as many as 1 million people commit suicide due to depression every year. Treatment for depression is urgent. In addition to the classic monoamine hypothesis, central nervous system immune dysregulation plays a key role in it. Microglia are the main immune cells of the nervous system, and when stimulated by signals, the resting microglia are activated into the classically activated M1 type or the selectively activated M2 type. M1 microglia secrete iNOS, TNF-α, ROS and other pro-inflammatory factors, which play an important ro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/415A61P25/24
CPCA61K31/415A61P25/24
Inventor 镇学初田盛刘纯
Owner SUZHOU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com